Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:25 PM
Ignite Modification Date:
2025-12-24 @ 7:25 PM
NCT ID:
NCT06828003
Eligibility Criteria:
Inclusion Criteria:
* ≥18 years of age
* localized or asymptomatic metastatic primary prostate cancer (i.e., androgen receptor axis agents \[ARATs\] including conventional ADT, abiraterone, enzalutamide)
* a history of ADT treatment
* not currently undergoing radiation
* no neurological or musculoskeletal co-morbidity inhibiting exercise
* mild cognitive impairment as determined by the TICS-M \[scores between 21-24 to separate individuals with mild cognitive impairment and normal cognition (\>24)\]
* not physically active (self-report \<90 minutes of MVPA/week and \<2 days of RT/week)
* physician clearance to participate
* access to a webcam and internet
* able to complete the study in English.
Exclusion Criteria:
* a medical condition that prevents unsupervised exercise
* presence of other primary or recurrent invasive cancer
* have experienced a fall in the last 12 months
* use a gait aid device
* current participation in other exercise programs/trials
* colour-blind since the objective cognitive tests require participants to distinguish between colours.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT06828003
Study Brief:
Protocol Section:
NCT06828003